Sophocleous A - Search Results

1

Association of cannabinoid receptor modulation with normal and abnormal skeletal remodelling: A systematic review and meta-analysis of in vitro, in vivo and human studies.

Sophocleous A, Yiallourides M, Zeng F, Pantelas P, Stylianou E, Li B, Carrasco G, Idris AI. Sophocleous A, et al. Pharmacol Res. 2022 Jan;175:105928. doi: 10.1016/j.phrs.2021.105928. Epub 2021 Nov 18. Pharmacol Res. 2022. PMID: 34800625

2

Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptor.

Idris AI, Sophocleous A, Landao-Bassonga E, van't Hof RJ, Ralston SH. Idris AI, et al. Among authors: sophocleous a. Endocrinology. 2008 Nov;149(11):5619-26. doi: 10.1210/en.2008-0150. Epub 2008 Jul 17. Endocrinology. 2008. PMID: 18635663

3

Cannabinoid receptor type 1 protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cells.

Idris AI, Sophocleous A, Landao-Bassonga E, Canals M, Milligan G, Baker D, van't Hof RJ, Ralston SH. Idris AI, et al. Among authors: sophocleous a. Cell Metab. 2009 Aug;10(2):139-47. doi: 10.1016/j.cmet.2009.07.006. Cell Metab. 2009. PMID: 19656492 Free article.

4

The type 2 cannabinoid receptor regulates bone mass and ovariectomy-induced bone loss by affecting osteoblast differentiation and bone formation.

Sophocleous A, Landao-Bassonga E, Van't Hof RJ, Idris AI, Ralston SH. Sophocleous A, et al. Endocrinology. 2011 Jun;152(6):2141-9. doi: 10.1210/en.2010-0930. Epub 2011 Mar 29. Endocrinology. 2011. PMID: 21447627

5

Selective tyrosine kinase inhibition of insulin-like growth factor-1 receptor inhibits human and mouse breast cancer-induced bone cell activity, bone remodeling, and osteolysis.

Logan JG, Sophocleous A, Marino S, Muir M, Brunton VG, Idris AI. Logan JG, et al. Among authors: sophocleous a. J Bone Miner Res. 2013 May;28(5):1229-42. doi: 10.1002/jbmr.1847. J Bone Miner Res. 2013. PMID: 23239200 Free article.

6

Genetic background modifies the effects of type 2 cannabinoid receptor deficiency on bone mass and bone turnover.

Sophocleous A, Idris AI, Ralston SH. Sophocleous A, et al. Calcif Tissue Int. 2014 Mar;94(3):259-68. doi: 10.1007/s00223-013-9793-8. Epub 2013 Sep 14. Calcif Tissue Int. 2014. PMID: 24036631

7

Modulation of strain-specific differences in gene expression by cannabinoid type 2 receptor deficiency.

Sophocleous A, Sims AH, Idris AI, Ralston SH. Sophocleous A, et al. Calcif Tissue Int. 2014 Apr;94(4):423-32. doi: 10.1007/s00223-013-9823-6. Epub 2013 Dec 27. Calcif Tissue Int. 2014. PMID: 24370613

8

Rodent models of osteoporosis.

Sophocleous A, Idris AI. Sophocleous A, et al. Bonekey Rep. 2014 Dec 10;3:614. doi: 10.1038/bonekey.2014.109. eCollection 2014. Bonekey Rep. 2014. PMID: 25852854 Free PMC article.

9

Bone Cell-autonomous Contribution of Type 2 Cannabinoid Receptor to Breast Cancer-induced Osteolysis.

Sophocleous A, Marino S, Logan JG, Mollat P, Ralston SH, Idris AI. Sophocleous A, et al. J Biol Chem. 2015 Sep 4;290(36):22049-60. doi: 10.1074/jbc.M115.649608. Epub 2015 Jul 20. J Biol Chem. 2015. PMID: 26195631 Free PMC article.

10

Combined deficiency of the Cnr1 and Cnr2 receptors protects against age-related bone loss by osteoclast inhibition.

Sophocleous A, Marino S, Kabir D, Ralston SH, Idris AI. Sophocleous A, et al. Aging Cell. 2017 Oct;16(5):1051-1061. doi: 10.1111/acel.12638. Epub 2017 Jul 28. Aging Cell. 2017. PMID: 28752643 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters